Hypertension and diabetes

E Grossman, FH Messerli - Cardiovascular diabetology: Clinical …, 2008 - karger.com
Both essential hypertension and diabetes mellitus affect the same major target organs. The
common denominator of hypertensive/diabetic target organ-disease is the vascular tree. Left …

[引用][C] Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008)

Desarrollada en colaboración con la Heart … - Revista española de …, 2008 - Elsevier Doyma

[HTML][HTML] Beneficial effects of Waon therapy on patients with chronic heart failure: results of a prospective multicenter study

M Miyata, T Kihara, T Kubozono, Y Ikeda, T Shinsato… - Journal of …, 2008 - Elsevier
BACKGROUND: We conducted a prospective multicenter case–control study to confirm the
clinical efficacy and safety of Waon therapy on chronic heart failure (CHF). METHODS …

[PDF][PDF] ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008

R De Caterina, V Dean, K Dickstein… - European Heart …, 2008 - sigmund-silber.com
Downloaded from disclosure forms are kept on file at the European Heart House,
headquarters of the ESC. Any changes in conflict of interest that arise during the writing …

Angiotensin receptor blockers: current status and future prospects

CVS Ram - The American journal of medicine, 2008 - Elsevier
Angiotensin receptor blockers (ARBs), through their physiological blockade of the renin-
angiotensin system, reduce morbidity and mortality associated with hypertension, heart …

Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction …

PA Meredith, J Östergren, I Anand, M Puu… - Journal of the American …, 2008 - jacc.org
Objectives: This study sought to investigate the efficacy and tolerability of candesartan,
according to baseline blood pressure (BP), in the 4,576 patients with a low ejection fraction …

Effect of atrial natriuretic peptide on adiponectin in patients with heart failure

T Tanaka, T Tsutamoto, H Sakai… - European journal of …, 2008 - Wiley Online Library
Background: The adipocyte‐specific cytokine adiponectin, has cardioprotective effects,
correlates with endogenous cardiac natriuretic peptides and adipocyte has guanylyl cyclase …

The therapeutic role of RAS blockade in chronic heart failure

CM Werner, M Böhm - Therapeutic Advances in …, 2008 - journals.sagepub.com
Cardiovascular disease represents a continuum that starts with risk factors such as
hypertension and progresses to atherosclerosis, end-organ damage, and ultimately to …

Diastolic heart failure

R Gary, L Davis - Heart & Lung, 2008 - Elsevier
Diastolic heart failure (DHF) is estimated to occur in 40% to 50% of patients with heart
failure. Evidence suggests that DHF is primarily a cardiogeriatric syndrome that increases …

Adverse drug reactions in patients with cardiovascular disease

MD Faulx, GS Francis - Current problems in cardiology, 2008 - Elsevier
Adverse drug reactions (ADRs) occur frequently in modern medical practice, resulting in
increased morbidity and mortality and a higher cost of care. Patients with cardiovascular …